img

Global Intravitreal Injectable Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Intravitreal Injectable Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Intravitreal Injectable are shot of medicine into the eye. It was first used to administer drugs to treat endophthalmitis and cytomegalovirus retinitis. Recently, it is used to treat age-related macular degeneration and many other retinal diseases as well.
Intravitreal Injectable report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Intravitreal Injectable market is projected to reach US$ 23620 million in 2034, increasing from US$ 14530 million in 2022, with the CAGR of 7.1% during the period of 2024 to 2034. Demand from Macular Degeneration and Macular Edema are the major drivers for the industry.
Global Intravitreal Injectable key players include Regeneron Pharmaceuticals (Eylea), Allergan, EyePoint Pharmaceuticals, Genentech, Kanghong Pharmaceutical, etc. Global top five manufacturers hold a share over 70%.
North Amercia is the largest market, with a share over 50%, followed by Europe and Asia-Pacific, both have a share over 40 percent.In terms of drug, Anti-VEGF is the largest segment, with a share over 85%. And in terms of disease, the largest application is Macular Edema, followed by Macular Degeneration, Retinal Vein Occlusion, etc.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Intravitreal Injectable market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Drug, Disease and Regions Listed in the Report



By Company


Regeneron Pharmaceuticals (Eylea)
Allergan
EyePoint Pharmaceuticals
Genentech
Kanghong Pharmaceutical
Segment by Drug
Anti-VEGF
Steroids
Others
Segment by Disease
Macular Degeneration
Macular Edema
Uveitis
Retinal Vein Occlusion
Others

Segment by Region


North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Intravitreal Injectable market further
Chapter 1Product Definition, Product Drugs, Volume and Revenue analysis of Each Drug in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Intravitreal Injectable, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Intravitreal Injectable industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Intravitreal Injectable in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Disease, Volume and Revenue analysis of Each Disease in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Intravitreal Injectable introduction, etc. Intravitreal Injectable Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Intravitreal Injectable market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.

Table of Content

1 Intravitreal Injectable Market Overview
1.1 Intravitreal Injectable Product Overview
1.2 Intravitreal Injectable Market Segment by Drug
1.2.1 Anti-VEGF
1.2.2 Steroids
1.2.3 Others
1.3 Global Intravitreal Injectable Market Size by Drug
1.3.1 Global Intravitreal Injectable Market Size Overview by Drug (2018-2034)
1.3.2 Global Intravitreal Injectable Historic Market Size Review by Drug (2018-2024)
1.3.3 Global Intravitreal Injectable Forecasted Market Size by Drug (2024-2034)
1.4 Key Regions Market Size Segment by Drug
1.4.1 North America Intravitreal Injectable Sales Breakdown by Drug (2018-2024)
1.4.2 Europe Intravitreal Injectable Sales Breakdown by Drug (2018-2024)
1.4.3 Asia-Pacific Intravitreal Injectable Sales Breakdown by Drug (2018-2024)
1.4.4 Latin America Intravitreal Injectable Sales Breakdown by Drug (2018-2024)
1.4.5 Middle East and Africa Intravitreal Injectable Sales Breakdown by Drug (2018-2024)
2 Global Intravitreal Injectable Market Competition by Company
2.1 Global Top Players by Intravitreal Injectable Sales (2018-2024)
2.2 Global Top Players by Intravitreal Injectable Revenue (2018-2024)
2.3 Global Top Players by Intravitreal Injectable Price (2018-2024)
2.4 Global Top Manufacturers Intravitreal Injectable Manufacturing Base Distribution, Sales Area, Product Type
2.5 Intravitreal Injectable Market Competitive Situation and Trends
2.5.1 Intravitreal Injectable Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Intravitreal Injectable Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Intravitreal Injectable as of 2022)
2.7 Date of Key Manufacturers Enter into Intravitreal Injectable Market
2.8 Key Manufacturers Intravitreal Injectable Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Intravitreal Injectable Status and Outlook by Region
3.1 Global Intravitreal Injectable Market Size and CAGR by Region: 2018 VS 2022 VS 2034
3.2 Global Intravitreal Injectable Historic Market Size by Region
3.2.1 Global Intravitreal Injectable Sales in Volume by Region (2018-2024)
3.2.2 Global Intravitreal Injectable Sales in Value by Region (2018-2024)
3.2.3 Global Intravitreal Injectable Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global Intravitreal Injectable Forecasted Market Size by Region
3.3.1 Global Intravitreal Injectable Sales in Volume by Region (2024-2034)
3.3.2 Global Intravitreal Injectable Sales in Value by Region (2024-2034)
3.3.3 Global Intravitreal Injectable Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global Intravitreal Injectable by Disease
4.1 Intravitreal Injectable Market Segment by Disease
4.1.1 Macular Degeneration
4.1.2 Macular Edema
4.1.3 Uveitis
4.1.4 Retinal Vein Occlusion
4.1.5 Others
4.2 Global Intravitreal Injectable Market Size by Disease
4.2.1 Global Intravitreal Injectable Market Size Overview by Disease (2018-2034)
4.2.2 Global Intravitreal Injectable Historic Market Size Review by Disease (2018-2024)
4.2.3 Global Intravitreal Injectable Forecasted Market Size by Disease (2024-2034)
4.3 Key Regions Market Size Segment by Disease
4.3.1 North America Intravitreal Injectable Sales Breakdown by Disease (2018-2024)
4.3.2 Europe Intravitreal Injectable Sales Breakdown by Disease (2018-2024)
4.3.3 Asia-Pacific Intravitreal Injectable Sales Breakdown by Disease (2018-2024)
4.3.4 Latin America Intravitreal Injectable Sales Breakdown by Disease (2018-2024)
4.3.5 Middle East and Africa Intravitreal Injectable Sales Breakdown by Disease (2018-2024)
5 North America Intravitreal Injectable by Country
5.1 North America Intravitreal Injectable Historic Market Size by Country
5.1.1 North America Intravitreal Injectable Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
5.1.2 North America Intravitreal Injectable Sales in Volume by Country (2018-2024)
5.1.3 North America Intravitreal Injectable Sales in Value by Country (2018-2024)
5.2 North America Intravitreal Injectable Forecasted Market Size by Country
5.2.1 North America Intravitreal Injectable Sales in Volume by Country (2024-2034)
5.2.2 North America Intravitreal Injectable Sales in Value by Country (2024-2034)
6 Europe Intravitreal Injectable by Country
6.1 Europe Intravitreal Injectable Historic Market Size by Country
6.1.1 Europe Intravitreal Injectable Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
6.1.2 Europe Intravitreal Injectable Sales in Volume by Country (2018-2024)
6.1.3 Europe Intravitreal Injectable Sales in Value by Country (2018-2024)
6.2 Europe Intravitreal Injectable Forecasted Market Size by Country
6.2.1 Europe Intravitreal Injectable Sales in Volume by Country (2024-2034)
6.2.2 Europe Intravitreal Injectable Sales in Value by Country (2024-2034)
7 Asia-Pacific Intravitreal Injectable by Region
7.1 Asia-Pacific Intravitreal Injectable Historic Market Size by Region
7.1.1 Asia-Pacific Intravitreal Injectable Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2034
7.1.2 Asia-Pacific Intravitreal Injectable Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific Intravitreal Injectable Sales in Value by Region (2018-2024)
7.2 Asia-Pacific Intravitreal Injectable Forecasted Market Size by Region
7.2.1 Asia-Pacific Intravitreal Injectable Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific Intravitreal Injectable Sales in Value by Region (2024-2034)
8 Latin America Intravitreal Injectable by Country
8.1 Latin America Intravitreal Injectable Historic Market Size by Country
8.1.1 Latin America Intravitreal Injectable Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
8.1.2 Latin America Intravitreal Injectable Sales in Volume by Country (2018-2024)
8.1.3 Latin America Intravitreal Injectable Sales in Value by Country (2018-2024)
8.2 Latin America Intravitreal Injectable Forecasted Market Size by Country
8.2.1 Latin America Intravitreal Injectable Sales in Volume by Country (2024-2034)
8.2.2 Latin America Intravitreal Injectable Sales in Value by Country (2024-2034)
9 Middle East and Africa Intravitreal Injectable by Country
9.1 Middle East and Africa Intravitreal Injectable Historic Market Size by Country
9.1.1 Middle East and Africa Intravitreal Injectable Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
9.1.2 Middle East and Africa Intravitreal Injectable Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa Intravitreal Injectable Sales in Value by Country (2018-2024)
9.2 Middle East and Africa Intravitreal Injectable Forecasted Market Size by Country
9.2.1 Middle East and Africa Intravitreal Injectable Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa Intravitreal Injectable Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 Regeneron Pharmaceuticals (Eylea)
10.1.1 Regeneron Pharmaceuticals (Eylea) Company Information
10.1.2 Regeneron Pharmaceuticals (Eylea) Introduction and Business Overview
10.1.3 Regeneron Pharmaceuticals (Eylea) Intravitreal Injectable Sales, Revenue and Gross Margin (2018-2024)
10.1.4 Regeneron Pharmaceuticals (Eylea) Intravitreal Injectable Products Offered
10.1.5 Regeneron Pharmaceuticals (Eylea) Recent Development
10.2 Allergan
10.2.1 Allergan Company Information
10.2.2 Allergan Introduction and Business Overview
10.2.3 Allergan Intravitreal Injectable Sales, Revenue and Gross Margin (2018-2024)
10.2.4 Allergan Intravitreal Injectable Products Offered
10.2.5 Allergan Recent Development
10.3 EyePoint Pharmaceuticals
10.3.1 EyePoint Pharmaceuticals Company Information
10.3.2 EyePoint Pharmaceuticals Introduction and Business Overview
10.3.3 EyePoint Pharmaceuticals Intravitreal Injectable Sales, Revenue and Gross Margin (2018-2024)
10.3.4 EyePoint Pharmaceuticals Intravitreal Injectable Products Offered
10.3.5 EyePoint Pharmaceuticals Recent Development
10.4 Genentech
10.4.1 Genentech Company Information
10.4.2 Genentech Introduction and Business Overview
10.4.3 Genentech Intravitreal Injectable Sales, Revenue and Gross Margin (2018-2024)
10.4.4 Genentech Intravitreal Injectable Products Offered
10.4.5 Genentech Recent Development
10.5 Kanghong Pharmaceutical
10.5.1 Kanghong Pharmaceutical Company Information
10.5.2 Kanghong Pharmaceutical Introduction and Business Overview
10.5.3 Kanghong Pharmaceutical Intravitreal Injectable Sales, Revenue and Gross Margin (2018-2024)
10.5.4 Kanghong Pharmaceutical Intravitreal Injectable Products Offered
10.5.5 Kanghong Pharmaceutical Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Intravitreal Injectable Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Intravitreal Injectable Industrial Chain Analysis
11.4 Intravitreal Injectable Market Dynamics
11.4.1 Intravitreal Injectable Industry Trends
11.4.2 Intravitreal Injectable Market Drivers
11.4.3 Intravitreal Injectable Market Challenges
11.4.4 Intravitreal Injectable Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Intravitreal Injectable Distributors
12.3 Intravitreal Injectable Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Anti-VEGF
Table 2. Major Company of Steroids
Table 3. Major Company of Others
Table 4. Global Intravitreal Injectable Sales by Drug 2018 VS 2022 VS 2034 (US$ Million)
Table 5. Global Intravitreal Injectable Sales by Drug (2018-2024) & (K Units)
Table 6. Global Intravitreal Injectable Sales Market Share in Volume by Drug (2018-2024)
Table 7. Global Intravitreal Injectable Sales by Drug (2018-2024) & (US& Million)
Table 8. Global Intravitreal Injectable Market Share in Value by Drug (2018-2024)
Table 9. Global Intravitreal Injectable Price by Drug (2018-2024) & (US$/Unit)
Table 10. Global Intravitreal Injectable Sales by Drug (2024-2034) & (K Units)
Table 11. Global Intravitreal Injectable Sales Market Share in Volume by Drug (2024-2034)
Table 12. Global Intravitreal Injectable Sales by Drug (2024-2034) & (US$ Million)
Table 13. Global Intravitreal Injectable Sales Market Share in Value by Drug (2024-2034)
Table 14. Global Intravitreal Injectable Price by Drug (2024-2034) & (US$/Unit)
Table 15. North America Intravitreal Injectable Sales by Drug (2018-2024) & (K Units)
Table 16. North America Intravitreal Injectable Sales by Drug (2018-2024) & (US$ Million)
Table 17. Europe Intravitreal Injectable Sales (K Units) by Drug (2018-2024)
Table 18. Europe Intravitreal Injectable Sales by Drug (2018-2024) & (US$ Million)
Table 19. Asia-Pacific Intravitreal Injectable Sales (K Units) by Drug (2018-2024)
Table 20. Asia-Pacific Intravitreal Injectable Sales by Drug (2018-2024) & (US$ Million)
Table 21. Latin America Intravitreal Injectable Sales (K Units) by Drug (2018-2024)
Table 22. Latin America Intravitreal Injectable Sales by Drug (2018-2024) & (US$ Million)
Table 23. Middle East and Africa Intravitreal Injectable Sales (K Units) by Drug (2018-2024)
Table 24. Middle East and Africa Intravitreal Injectable Sales by Drug (2018-2024) & (US$ Million)
Table 25. Global Intravitreal Injectable Sales by Company (2018-2024) & (K Units)
Table 26. Global Intravitreal Injectable Sales Share by Company (2018-2024)
Table 27. Global Intravitreal Injectable Revenue by Company (2018-2024) & (US$ Million)
Table 28. Global Intravitreal Injectable Revenue Share by Company (2018-2024)
Table 29. Global Market Intravitreal Injectable Price by Company (2018-2024) & (US$/Unit)
Table 30. Global Intravitreal Injectable Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 31. Global Intravitreal Injectable Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 32. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Intravitreal Injectable as of 2022)
Table 33. Date of Key Manufacturers Enter into Intravitreal Injectable Market
Table 34. Key Manufacturers Intravitreal Injectable Product Type
Table 35. Mergers & Acquisitions, Expansion Plans
Table 36. Global Intravitreal Injectable Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2034
Table 37. Global Intravitreal Injectable Sales by Region (2018-2024) & (K Units)
Table 38. Global Intravitreal Injectable Sales Market Share in Volume by Region (2018-2024)
Table 39. Global Intravitreal Injectable Sales by Region (2018-2024) & (US$ Million)
Table 40. Global Intravitreal Injectable Sales Market Share in Value by Region (2018-2024)
Table 41. Global Intravitreal Injectable Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 42. Global Intravitreal Injectable Sales by Region (2024-2034) & (K Units)
Table 43. Global Intravitreal Injectable Sales Market Share in Volume by Region (2024-2034)
Table 44. Global Intravitreal Injectable Sales by Region (2024-2034) & (US$ Million)
Table 45. Global Intravitreal Injectable Sales Market Share in Value by Region (2024-2034)
Table 46. Global Intravitreal Injectable Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2034)
Table 47. Global Intravitreal Injectable Sales by Disease: 2018 VS 2022 VS 2034 (US$ Million)
Table 48. Global Intravitreal Injectable Sales by Disease (2018-2024) & (K Units)
Table 49. Global Intravitreal Injectable Sales Market Share in Volume by Disease (2018-2024)
Table 50. Global Intravitreal Injectable Sales by Disease (2018-2024) & (US$ Million)
Table 51. Global Intravitreal Injectable Sales Market Share in Value by Disease (2018-2024)
Table 52. Global Intravitreal Injectable Price by Disease (2018-2024) & (US$/Unit)
Table 53. Global Intravitreal Injectable Sales by Disease (2024-2034) & (K Units)
Table 54. Global Intravitreal Injectable Sales Market Share in Volume by Disease (2024-2034)
Table 55. Global Intravitreal Injectable Sales by Disease (2024-2034) & (US$ Million)
Table 56. Global Intravitreal Injectable Sales Market Share in Value by Disease (2024-2034)
Table 57. Global Intravitreal Injectable Price by Disease (2024-2034) & (US$/Unit)
Table 58. North America Intravitreal Injectable Sales by Disease (2018-2024) (K Units)
Table 59. North America Intravitreal Injectable Sales by Disease (2018-2024) & (US$ Million)
Table 60. Europe Intravitreal Injectable Sales by Disease (2018-2024) (K Units)
Table 61. Europe Intravitreal Injectable Sales by Disease (2018-2024) & (US$ Million)
Table 62. Asia-Pacific Intravitreal Injectable Sales by Disease (2018-2024) (K Units)
Table 63. Asia-Pacific Intravitreal Injectable Sales by Disease (2018-2024) & (US$ Million)
Table 64. Latin America Intravitreal Injectable Sales by Disease (2018-2024) (K Units)
Table 65. Latin America Intravitreal Injectable Sales by Disease (2018-2024) & (US$ Million)
Table 66. Middle East and Africa Intravitreal Injectable Sales by Disease (2018-2024) (K Units)
Table 67. Middle East and Africa Intravitreal Injectable Sales by Disease (2018-2024) & (US$ Million)
Table 68. North America Intravitreal Injectable Sales by Country (2018-2024) & (K Units)
Table 69. North America Intravitreal Injectable Sales Market Share in Volume by Country (2018-2024)
Table 70. North America Intravitreal Injectable Sales by Country (2018-2024) & (US$ Million)
Table 71. North America Intravitreal Injectable Sales Market Share in Value by Country (2018-2024)
Table 72. North America Intravitreal Injectable Sales by Country (2024-2034) & (K Units)
Table 73. North America Intravitreal Injectable Sales Market Share in Volume by Country (2024-2034)
Table 74. North America Intravitreal Injectable Sales by Country (2024-2034) & (US$ Million)
Table 75. North America Intravitreal Injectable Sales Market Share in Value by Country (2024-2034)
Table 76. Europe Intravitreal Injectable Sales by Country (2018-2024) & (K Units)
Table 77. Europe Intravitreal Injectable Sales Market Share in Volume by Country (2018-2024)
Table 78. Europe Intravitreal Injectable Sales by Country (2018-2024) & (US$ Million)
Table 79. Europe Intravitreal Injectable Sales Market Share in Value by Country (2018-2024)
Table 80. Europe Intravitreal Injectable Sales by Country (2024-2034) & (K Units)
Table 81. Europe Intravitreal Injectable Sales Market Share in Volume by Country (2024-2034)
Table 82. Europe Intravitreal Injectable Sales by Country (2024-2034) & (US$ Million)
Table 83. Europe Intravitreal Injectable Sales Market Share in Value by Country (2024-2034)
Table 84. Asia-Pacific Intravitreal Injectable Sales by Region (2018-2024) & (K Units)
Table 85. Asia-Pacific Intravitreal Injectable Sales Market Share in Volume by Region (2018-2024)
Table 86. Asia-Pacific Intravitreal Injectable Sales by Region (2018-2024) & (US$ Million)
Table 87. Asia-Pacific Intravitreal Injectable Sales Market Share in Value by Region (2018-2024)
Table 88. Asia-Pacific Intravitreal Injectable Sales by Region (2024-2034) & (K Units)
Table 89. Asia-Pacific Intravitreal Injectable Sales Market Share in Volume by Region (2024-2034)
Table 90. Asia-Pacific Intravitreal Injectable Sales by Region (2024-2034) & (US$ Million)
Table 91. Asia-Pacific Intravitreal Injectable Sales Market Share in Value by Region (2024-2034)
Table 92. Latin America Intravitreal Injectable Sales by Country (2018-2024) & (K Units)
Table 93. Latin America Intravitreal Injectable Sales Market Share in Volume by Country (2018-2024)
Table 94. Latin America Intravitreal Injectable Sales by Country (2018-2024) & (US$ Million)
Table 95. Latin America Intravitreal Injectable Sales Market Share in Value by Country (2018-2024)
Table 96. Latin America Intravitreal Injectable Sales by Country (2024-2034) & (K Units)
Table 97. Latin America Intravitreal Injectable Sales Market Share in Volume by Country (2024-2034)
Table 98. Latin America Intravitreal Injectable Sales by Country (2024-2034) & (US$ Million)
Table 99. Latin America Intravitreal Injectable Sales Market Share in Value by Country (2024-2034)
Table 100. Middle East and Africa Intravitreal Injectable Sales by Country (2018-2024) & (K Units)
Table 101. Middle East and Africa Intravitreal Injectable Sales Market Share in Volume by Country (2018-2024)
Table 102. Middle East and Africa Intravitreal Injectable Sales by Country (2018-2024) & (US$ Million)
Table 103. Middle East and Africa Intravitreal Injectable Sales Market Share in Value by Country (2018-2024)
Table 104. Middle East and Africa Intravitreal Injectable Sales by Country (2024-2034) & (K Units)
Table 105. Middle East and Africa Intravitreal Injectable Sales Market Share in Volume by Country (2024-2034)
Table 106. Middle East and Africa Intravitreal Injectable Sales by Country (2024-2034) & (US$ Million)
Table 107. Middle East and Africa Intravitreal Injectable Sales Market Share in Value by Country (2024-2034)
Table 108. Regeneron Pharmaceuticals (Eylea) Company Information
Table 109. Regeneron Pharmaceuticals (Eylea) Introduction and Business Overview
Table 110. Regeneron Pharmaceuticals (Eylea) Intravitreal Injectable Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 111. Regeneron Pharmaceuticals (Eylea) Intravitreal Injectable Product
Table 112. Regeneron Pharmaceuticals (Eylea) Recent Development
Table 113. Allergan Company Information
Table 114. Allergan Introduction and Business Overview
Table 115. Allergan Intravitreal Injectable Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 116. Allergan Intravitreal Injectable Product
Table 117. Allergan Recent Development
Table 118. EyePoint Pharmaceuticals Company Information
Table 119. EyePoint Pharmaceuticals Introduction and Business Overview
Table 120. EyePoint Pharmaceuticals Intravitreal Injectable Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 121. EyePoint Pharmaceuticals Intravitreal Injectable Product
Table 122. EyePoint Pharmaceuticals Recent Development
Table 123. Genentech Company Information
Table 124. Genentech Introduction and Business Overview
Table 125. Genentech Intravitreal Injectable Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 126. Genentech Intravitreal Injectable Product
Table 127. Genentech Recent Development
Table 128. Kanghong Pharmaceutical Company Information
Table 129. Kanghong Pharmaceutical Introduction and Business Overview
Table 130. Kanghong Pharmaceutical Intravitreal Injectable Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 131. Kanghong Pharmaceutical Intravitreal Injectable Product
Table 132. Kanghong Pharmaceutical Recent Development
Table 133. Key Raw Materials Lists
Table 134. Raw Materials Key Suppliers Lists
Table 135. Intravitreal Injectable Market Trends
Table 136. Intravitreal Injectable Market Drivers
Table 137. Intravitreal Injectable Market Challenges
Table 138. Intravitreal Injectable Market Restraints
Table 139. Intravitreal Injectable Distributors List
Table 140. Intravitreal Injectable Downstream Customers
Table 141. Research Programs/Design for This Report
Table 142. Key Data Information from Secondary Sources
Table 143. Key Data Information from Primary Sources
List of Figures
Figure 1. Intravitreal Injectable Product Picture
Figure 2. Global Intravitreal Injectable Market Size, 2018 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Intravitreal Injectable Market Size Status and Outlook (2018-2034) & (US$ Million)
Figure 4. Global Intravitreal Injectable Sales Status and Outlook (2018-2034) & (K Units)
Figure 5. Product Picture of Anti-VEGF
Figure 6. Global Anti-VEGF Sales YoY Growth (2018-2034) & (K Units)
Figure 7. Product Picture of Steroids
Figure 8. Global Steroids Sales YoY Growth (2018-2034) & (K Units)
Figure 9. Product Picture of Others
Figure 10. Global Others Sales YoY Growth (2018-2034) & (K Units)
Figure 11. Global Intravitreal Injectable Sales by Drug (2018-2034) & (US$ Million)
Figure 12. Global Intravitreal Injectable Sales Market Share by Drug in 2022 & 2034
Figure 13. North America Intravitreal Injectable Sales Market Share in Volume by Drug in 2022
Figure 14. North America Intravitreal Injectable Sales Market Share in Value by Drug in 2022
Figure 15. Europe Intravitreal Injectable Sales Market Share in Volume by Drug in 2022
Figure 16. Europe Intravitreal Injectable Sales Market Share in Value by Drug in 2022
Figure 17. Asia-Pacific Intravitreal Injectable Sales Market Share in Volume by Drug in 2022
Figure 18. Asia-Pacific Intravitreal Injectable Sales Market Share in Value by Drug in 2022
Figure 19. Latin America Intravitreal Injectable Sales Market Share in Volume by Drug in 2022
Figure 20. Latin America Intravitreal Injectable Sales Market Share in Value by Drug in 2022
Figure 21. Middle East and Africa Intravitreal Injectable Sales Market Share in Volume by Drug in 2022
Figure 22. Middle East and Africa Intravitreal Injectable Sales Market Share in Value by Drug in 2022
Figure 23. The 5 and 10 Largest Manufacturers in the World: Market Share by Intravitreal Injectable Sales in 2022
Figure 24. The 5 and 10 Largest Manufacturers in the World: Market Share by Intravitreal Injectable Revenue in 2022
Figure 25. Intravitreal Injectable Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 26. Product Picture of Macular Degeneration
Figure 27. Global Macular Degeneration Sales YoY Growth (2018-2034) & (K Units)
Figure 28. Product Picture of Macular Edema
Figure 29. Global Macular Edema Sales YoY Growth (2018-2034) & (K Units)
Figure 30. Product Picture of Uveitis
Figure 31. Global Uveitis Sales YoY Growth (2018-2034) & (K Units)
Figure 32. Product Picture of Retinal Vein Occlusion
Figure 33. Global Retinal Vein Occlusion Sales YoY Growth (2018-2034) & (K Units)
Figure 34. Product Picture of Others
Figure 35. Global Others Sales YoY Growth (2018-2034) & (K Units)
Figure 36. Global Intravitreal Injectable Sales by Disease (2018-2034) & (US$ Million)
Figure 37. Global Intravitreal Injectable Sales Market Share by Disease in 2022 & 2034
Figure 38. North America Intravitreal Injectable Sales Market Share in Volume by Disease in 2022
Figure 39. North America Intravitreal Injectable Sales Market Share in Value by Disease in 2022
Figure 40. Europe Intravitreal Injectable Sales Market Share in Volume by Disease in 2022
Figure 41. Europe Intravitreal Injectable Sales Market Share in Value by Disease in 2022
Figure 42. Asia-Pacific Intravitreal Injectable Sales Market Share in Volume by Disease in 2022
Figure 43. Asia-Pacific Intravitreal Injectable Sales Market Share in Value by Disease in 2022
Figure 44. Latin America Intravitreal Injectable Sales Market Share in Volume by Disease in 2022
Figure 45. Latin America Intravitreal Injectable Sales Market Share in Value by Disease in 2022
Figure 46. Middle East and Africa Intravitreal Injectable Sales Market Share in Value by Disease in 2022
Figure 47. Key Raw Materials Price
Figure 48. Intravitreal Injectable Manufacturing Cost Structure
Figure 49. Intravitreal Injectable Industrial Chain Analysis
Figure 50. Channels of Distribution
Figure 51. Distributors Profiles
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
Figure 54. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries